Compass Therapeutics, Inc.
For the period ended Jun 30, 2025. Filed Aug 11, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 11, 2025
CMPX$0.76+10.8%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Compass Therapeutics, Inc. | ||
| Date: August 11, 2025 | By: | /s/ Thomas Schuetz |
|---|---|---|
| Thomas Schuetz | ||
| Principal Executive Officer | ||
| Date: August 11, 2025 | By: | /s/ Barry Shin |
| Barry Shin Principal Financial Officer | ||
| Date: August 11, 2025 | By: | /s/ Neil Lerner |
| Neil Lerner | ||
| Principal Accounting Officer | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.